nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—ABCB1—colon cancer	0.398	1	CbGaD
Nefazodone—CYP3A7—Irinotecan—colon cancer	0.0588	0.145	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0588	0.145	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0514	0.127	CbGbCtD
Nefazodone—CYP3A7—Vincristine—colon cancer	0.0514	0.127	CbGbCtD
Nefazodone—CYP3A5—Irinotecan—colon cancer	0.0441	0.109	CbGbCtD
Nefazodone—CYP3A5—Vincristine—colon cancer	0.0385	0.0954	CbGbCtD
Nefazodone—ABCB1—Irinotecan—colon cancer	0.0287	0.071	CbGbCtD
Nefazodone—ABCB1—Vincristine—colon cancer	0.0251	0.0621	CbGbCtD
Nefazodone—CYP3A4—Irinotecan—colon cancer	0.0172	0.0425	CbGbCtD
Nefazodone—ABCB1—Methotrexate—colon cancer	0.0152	0.0376	CbGbCtD
Nefazodone—CYP3A4—Vincristine—colon cancer	0.015	0.0372	CbGbCtD
Nefazodone—HTR2A—myenteric nerve plexus—colon cancer	0.00375	0.176	CbGeAlD
Nefazodone—HTR2A—vein—colon cancer	0.00242	0.114	CbGeAlD
Nefazodone—ADRA1B—renal system—colon cancer	0.000953	0.0448	CbGeAlD
Nefazodone—HTR2A—endothelium—colon cancer	0.000831	0.0391	CbGeAlD
Nefazodone—HTR2A—blood vessel—colon cancer	0.000766	0.0361	CbGeAlD
Nefazodone—CYP3A7—liver—colon cancer	0.000741	0.0349	CbGeAlD
Nefazodone—CYP3A7-CYP3A51P—liver—colon cancer	0.00063	0.0297	CbGeAlD
Nefazodone—HTR1A—renal system—colon cancer	0.000581	0.0273	CbGeAlD
Nefazodone—ADRA1A—epithelium—colon cancer	0.000577	0.0272	CbGeAlD
Nefazodone—SLC6A4—digestive system—colon cancer	0.000536	0.0252	CbGeAlD
Nefazodone—ADRA1A—renal system—colon cancer	0.000535	0.0252	CbGeAlD
Nefazodone—ABCB1—blood vessel—colon cancer	0.000502	0.0236	CbGeAlD
Nefazodone—HTR2A—embryo—colon cancer	0.000457	0.0215	CbGeAlD
Nefazodone—ADRA1A—lymphoid tissue—colon cancer	0.000444	0.0209	CbGeAlD
Nefazodone—CYP3A5—renal system—colon cancer	0.000427	0.0201	CbGeAlD
Nefazodone—HTR2A—epithelium—colon cancer	0.000373	0.0176	CbGeAlD
Nefazodone—Vision blurred—Fluorouracil—colon cancer	0.000362	0.00207	CcSEcCtD
Nefazodone—Malaise—Irinotecan—colon cancer	0.000362	0.00207	CcSEcCtD
Nefazodone—Vertigo—Irinotecan—colon cancer	0.00036	0.00206	CcSEcCtD
Nefazodone—Dysuria—Capecitabine—colon cancer	0.00036	0.00206	CcSEcCtD
Nefazodone—Syncope—Irinotecan—colon cancer	0.00036	0.00205	CcSEcCtD
Nefazodone—HTR2A—smooth muscle tissue—colon cancer	0.000359	0.0169	CbGeAlD
Nefazodone—Leukopenia—Irinotecan—colon cancer	0.000359	0.00205	CcSEcCtD
Nefazodone—Convulsion—Vincristine—colon cancer	0.000357	0.00204	CcSEcCtD
Nefazodone—Hypertension—Vincristine—colon cancer	0.000355	0.00203	CcSEcCtD
Nefazodone—Anaemia—Fluorouracil—colon cancer	0.000355	0.00203	CcSEcCtD
Nefazodone—Loss of consciousness—Irinotecan—colon cancer	0.000352	0.00201	CcSEcCtD
Nefazodone—Photosensitivity reaction—Capecitabine—colon cancer	0.000351	0.00201	CcSEcCtD
Nefazodone—Myalgia—Vincristine—colon cancer	0.00035	0.002	CcSEcCtD
Nefazodone—Weight increased—Capecitabine—colon cancer	0.00035	0.002	CcSEcCtD
Nefazodone—CYP3A5—digestive system—colon cancer	0.00035	0.0165	CbGeAlD
Nefazodone—Visual disturbance—Methotrexate—colon cancer	0.00035	0.002	CcSEcCtD
Nefazodone—Cough—Irinotecan—colon cancer	0.00035	0.002	CcSEcCtD
Nefazodone—Weight decreased—Capecitabine—colon cancer	0.000348	0.00199	CcSEcCtD
Nefazodone—Hypertension—Irinotecan—colon cancer	0.000346	0.00198	CcSEcCtD
Nefazodone—HTR2A—renal system—colon cancer	0.000346	0.0163	CbGeAlD
Nefazodone—Pneumonia—Capecitabine—colon cancer	0.000345	0.00197	CcSEcCtD
Nefazodone—Leukopenia—Fluorouracil—colon cancer	0.000344	0.00196	CcSEcCtD
Nefazodone—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00034	0.00195	CcSEcCtD
Nefazodone—Cerebrovascular accident—Methotrexate—colon cancer	0.000338	0.00193	CcSEcCtD
Nefazodone—Discomfort—Irinotecan—colon cancer	0.000337	0.00193	CcSEcCtD
Nefazodone—Anaphylactic shock—Vincristine—colon cancer	0.000336	0.00192	CcSEcCtD
Nefazodone—Oedema—Vincristine—colon cancer	0.000336	0.00192	CcSEcCtD
Nefazodone—Stomatitis—Capecitabine—colon cancer	0.000335	0.00191	CcSEcCtD
Nefazodone—Infection—Vincristine—colon cancer	0.000334	0.00191	CcSEcCtD
Nefazodone—Urinary tract infection—Capecitabine—colon cancer	0.000334	0.00191	CcSEcCtD
Nefazodone—Conjunctivitis—Capecitabine—colon cancer	0.000334	0.00191	CcSEcCtD
Nefazodone—Convulsion—Fluorouracil—colon cancer	0.000333	0.0019	CcSEcCtD
Nefazodone—Osteoarthritis—Methotrexate—colon cancer	0.000332	0.0019	CcSEcCtD
Nefazodone—Confusional state—Irinotecan—colon cancer	0.00033	0.00189	CcSEcCtD
Nefazodone—Thrombocytopenia—Vincristine—colon cancer	0.000329	0.00188	CcSEcCtD
Nefazodone—Haematuria—Capecitabine—colon cancer	0.000327	0.00187	CcSEcCtD
Nefazodone—Oedema—Irinotecan—colon cancer	0.000327	0.00187	CcSEcCtD
Nefazodone—Anaphylactic shock—Irinotecan—colon cancer	0.000327	0.00187	CcSEcCtD
Nefazodone—ADRA1A—liver—colon cancer	0.000327	0.0154	CbGeAlD
Nefazodone—Myalgia—Fluorouracil—colon cancer	0.000327	0.00187	CcSEcCtD
Nefazodone—Chest pain—Fluorouracil—colon cancer	0.000327	0.00187	CcSEcCtD
Nefazodone—Infection—Irinotecan—colon cancer	0.000325	0.00186	CcSEcCtD
Nefazodone—Hyperhidrosis—Vincristine—colon cancer	0.000325	0.00186	CcSEcCtD
Nefazodone—Epistaxis—Capecitabine—colon cancer	0.000324	0.00185	CcSEcCtD
Nefazodone—Discomfort—Fluorouracil—colon cancer	0.000323	0.00185	CcSEcCtD
Nefazodone—Shock—Irinotecan—colon cancer	0.000322	0.00184	CcSEcCtD
Nefazodone—Thrombocytopenia—Irinotecan—colon cancer	0.00032	0.00183	CcSEcCtD
Nefazodone—CYP3A4—renal system—colon cancer	0.00032	0.0151	CbGeAlD
Nefazodone—Anorexia—Vincristine—colon cancer	0.00032	0.00183	CcSEcCtD
Nefazodone—Domperidone—ABCB1—colon cancer	0.000318	0.241	CrCbGaD
Nefazodone—Hyperhidrosis—Irinotecan—colon cancer	0.000316	0.00181	CcSEcCtD
Nefazodone—Confusional state—Fluorouracil—colon cancer	0.000316	0.00181	CcSEcCtD
Nefazodone—CYP2D6—renal system—colon cancer	0.000315	0.0148	CbGeAlD
Nefazodone—Mood swings—Methotrexate—colon cancer	0.000314	0.0018	CcSEcCtD
Nefazodone—Hypotension—Vincristine—colon cancer	0.000314	0.00179	CcSEcCtD
Nefazodone—Bradycardia—Capecitabine—colon cancer	0.000314	0.00179	CcSEcCtD
Nefazodone—Oedema—Fluorouracil—colon cancer	0.000313	0.00179	CcSEcCtD
Nefazodone—Anaphylactic shock—Fluorouracil—colon cancer	0.000313	0.00179	CcSEcCtD
Nefazodone—Anorexia—Irinotecan—colon cancer	0.000312	0.00178	CcSEcCtD
Nefazodone—Ataxia—Methotrexate—colon cancer	0.000312	0.00178	CcSEcCtD
Nefazodone—Infection—Fluorouracil—colon cancer	0.000311	0.00178	CcSEcCtD
Nefazodone—Haemoglobin—Capecitabine—colon cancer	0.00031	0.00177	CcSEcCtD
Nefazodone—CYP3A5—vagina—colon cancer	0.000309	0.0146	CbGeAlD
Nefazodone—Rhinitis—Capecitabine—colon cancer	0.000309	0.00177	CcSEcCtD
Nefazodone—Hepatitis—Capecitabine—colon cancer	0.000308	0.00176	CcSEcCtD
Nefazodone—Haemorrhage—Capecitabine—colon cancer	0.000308	0.00176	CcSEcCtD
Nefazodone—Thrombocytopenia—Fluorouracil—colon cancer	0.000307	0.00175	CcSEcCtD
Nefazodone—Hypoaesthesia—Capecitabine—colon cancer	0.000307	0.00175	CcSEcCtD
Nefazodone—Liver function test abnormal—Methotrexate—colon cancer	0.000306	0.00175	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Vincristine—colon cancer	0.000306	0.00175	CcSEcCtD
Nefazodone—Pharyngitis—Capecitabine—colon cancer	0.000306	0.00175	CcSEcCtD
Nefazodone—Tachycardia—Fluorouracil—colon cancer	0.000306	0.00175	CcSEcCtD
Nefazodone—Hypotension—Irinotecan—colon cancer	0.000306	0.00175	CcSEcCtD
Nefazodone—Insomnia—Vincristine—colon cancer	0.000304	0.00174	CcSEcCtD
Nefazodone—Oedema peripheral—Capecitabine—colon cancer	0.000304	0.00174	CcSEcCtD
Nefazodone—Paraesthesia—Vincristine—colon cancer	0.000302	0.00172	CcSEcCtD
Nefazodone—ABCB1—embryo—colon cancer	0.0003	0.0141	CbGeAlD
Nefazodone—Anorexia—Fluorouracil—colon cancer	0.000299	0.00171	CcSEcCtD
Nefazodone—Visual impairment—Capecitabine—colon cancer	0.000297	0.0017	CcSEcCtD
Nefazodone—Insomnia—Irinotecan—colon cancer	0.000296	0.00169	CcSEcCtD
Nefazodone—ADRA2A—vagina—colon cancer	0.000295	0.0139	CbGeAlD
Nefazodone—Paraesthesia—Irinotecan—colon cancer	0.000294	0.00168	CcSEcCtD
Nefazodone—Hypotension—Fluorouracil—colon cancer	0.000293	0.00167	CcSEcCtD
Nefazodone—Decreased appetite—Vincristine—colon cancer	0.000292	0.00167	CcSEcCtD
Nefazodone—Dyspnoea—Irinotecan—colon cancer	0.000292	0.00167	CcSEcCtD
Nefazodone—Erythema multiforme—Capecitabine—colon cancer	0.000291	0.00167	CcSEcCtD
Nefazodone—Somnolence—Irinotecan—colon cancer	0.000291	0.00166	CcSEcCtD
Nefazodone—Dyspepsia—Irinotecan—colon cancer	0.000288	0.00165	CcSEcCtD
Nefazodone—Tinnitus—Capecitabine—colon cancer	0.000287	0.00164	CcSEcCtD
Nefazodone—Constipation—Vincristine—colon cancer	0.000287	0.00164	CcSEcCtD
Nefazodone—Pain—Vincristine—colon cancer	0.000287	0.00164	CcSEcCtD
Nefazodone—Asthma—Methotrexate—colon cancer	0.000287	0.00164	CcSEcCtD
Nefazodone—Flushing—Capecitabine—colon cancer	0.000286	0.00163	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000285	0.00163	CcSEcCtD
Nefazodone—Decreased appetite—Irinotecan—colon cancer	0.000284	0.00163	CcSEcCtD
Nefazodone—HTR2A—digestive system—colon cancer	0.000284	0.0134	CbGeAlD
Nefazodone—Insomnia—Fluorouracil—colon cancer	0.000283	0.00162	CcSEcCtD
Nefazodone—Paraesthesia—Fluorouracil—colon cancer	0.000281	0.00161	CcSEcCtD
Nefazodone—Pain—Irinotecan—colon cancer	0.00028	0.0016	CcSEcCtD
Nefazodone—Constipation—Irinotecan—colon cancer	0.00028	0.0016	CcSEcCtD
Nefazodone—Dyspnoea—Fluorouracil—colon cancer	0.000279	0.0016	CcSEcCtD
Nefazodone—Somnolence—Fluorouracil—colon cancer	0.000279	0.00159	CcSEcCtD
Nefazodone—Chills—Capecitabine—colon cancer	0.000277	0.00158	CcSEcCtD
Nefazodone—Dyspepsia—Fluorouracil—colon cancer	0.000276	0.00158	CcSEcCtD
Nefazodone—Gastrointestinal pain—Vincristine—colon cancer	0.000275	0.00157	CcSEcCtD
Nefazodone—Decreased appetite—Fluorouracil—colon cancer	0.000272	0.00156	CcSEcCtD
Nefazodone—Alopecia—Capecitabine—colon cancer	0.000272	0.00156	CcSEcCtD
Nefazodone—SLC6A2—lymph node—colon cancer	0.00027	0.0127	CbGeAlD
Nefazodone—Feeling abnormal—Irinotecan—colon cancer	0.00027	0.00154	CcSEcCtD
Nefazodone—Dysuria—Methotrexate—colon cancer	0.000268	0.00153	CcSEcCtD
Nefazodone—Pain—Fluorouracil—colon cancer	0.000268	0.00153	CcSEcCtD
Nefazodone—Gastrointestinal pain—Irinotecan—colon cancer	0.000268	0.00153	CcSEcCtD
Nefazodone—Body temperature increased—Vincristine—colon cancer	0.000266	0.00152	CcSEcCtD
Nefazodone—Abdominal pain—Vincristine—colon cancer	0.000266	0.00152	CcSEcCtD
Nefazodone—Flatulence—Capecitabine—colon cancer	0.000264	0.00151	CcSEcCtD
Nefazodone—Erectile dysfunction—Methotrexate—colon cancer	0.000264	0.00151	CcSEcCtD
Nefazodone—Dysgeusia—Capecitabine—colon cancer	0.000263	0.0015	CcSEcCtD
Nefazodone—CYP3A4—digestive system—colon cancer	0.000263	0.0124	CbGeAlD
Nefazodone—Photosensitivity reaction—Methotrexate—colon cancer	0.000262	0.0015	CcSEcCtD
Nefazodone—CYP3A5—liver—colon cancer	0.000261	0.0123	CbGeAlD
Nefazodone—Back pain—Capecitabine—colon cancer	0.00026	0.00148	CcSEcCtD
Nefazodone—Abdominal pain—Irinotecan—colon cancer	0.000259	0.00148	CcSEcCtD
Nefazodone—Body temperature increased—Irinotecan—colon cancer	0.000259	0.00148	CcSEcCtD
Nefazodone—CYP2D6—digestive system—colon cancer	0.000259	0.0122	CbGeAlD
Nefazodone—Feeling abnormal—Fluorouracil—colon cancer	0.000258	0.00148	CcSEcCtD
Nefazodone—Muscle spasms—Capecitabine—colon cancer	0.000258	0.00147	CcSEcCtD
Nefazodone—Pneumonia—Methotrexate—colon cancer	0.000257	0.00147	CcSEcCtD
Nefazodone—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000253	0.00145	CcSEcCtD
Nefazodone—Vision blurred—Capecitabine—colon cancer	0.000253	0.00145	CcSEcCtD
Nefazodone—Tremor—Capecitabine—colon cancer	0.000251	0.00144	CcSEcCtD
Nefazodone—HTR2A—vagina—colon cancer	0.000251	0.0118	CbGeAlD
Nefazodone—Stomatitis—Methotrexate—colon cancer	0.000249	0.00142	CcSEcCtD
Nefazodone—Ill-defined disorder—Capecitabine—colon cancer	0.000249	0.00142	CcSEcCtD
Nefazodone—Urticaria—Fluorouracil—colon cancer	0.000249	0.00142	CcSEcCtD
Nefazodone—Conjunctivitis—Methotrexate—colon cancer	0.000248	0.00142	CcSEcCtD
Nefazodone—Anaemia—Capecitabine—colon cancer	0.000248	0.00142	CcSEcCtD
Nefazodone—Body temperature increased—Fluorouracil—colon cancer	0.000248	0.00142	CcSEcCtD
Nefazodone—Hypersensitivity—Vincristine—colon cancer	0.000248	0.00141	CcSEcCtD
Nefazodone—Aripiprazole—ABCB1—colon cancer	0.000246	0.186	CrCbGaD
Nefazodone—Sweating—Methotrexate—colon cancer	0.000245	0.0014	CcSEcCtD
Nefazodone—Trazodone—ABCB1—colon cancer	0.000245	0.185	CrCbGaD
Nefazodone—ABCB1—epithelium—colon cancer	0.000244	0.0115	CbGeAlD
Nefazodone—Haematuria—Methotrexate—colon cancer	0.000244	0.00139	CcSEcCtD
Nefazodone—Malaise—Capecitabine—colon cancer	0.000242	0.00138	CcSEcCtD
Nefazodone—Epistaxis—Methotrexate—colon cancer	0.000241	0.00138	CcSEcCtD
Nefazodone—Vertigo—Capecitabine—colon cancer	0.000241	0.00138	CcSEcCtD
Nefazodone—Hypersensitivity—Irinotecan—colon cancer	0.000241	0.00138	CcSEcCtD
Nefazodone—Asthenia—Vincristine—colon cancer	0.000241	0.00138	CcSEcCtD
Nefazodone—Syncope—Capecitabine—colon cancer	0.000241	0.00138	CcSEcCtD
Nefazodone—Leukopenia—Capecitabine—colon cancer	0.00024	0.00137	CcSEcCtD
Nefazodone—Palpitations—Capecitabine—colon cancer	0.000237	0.00136	CcSEcCtD
Nefazodone—Loss of consciousness—Capecitabine—colon cancer	0.000236	0.00135	CcSEcCtD
Nefazodone—Asthenia—Irinotecan—colon cancer	0.000235	0.00134	CcSEcCtD
Nefazodone—Cough—Capecitabine—colon cancer	0.000234	0.00134	CcSEcCtD
Nefazodone—Hypertension—Capecitabine—colon cancer	0.000232	0.00132	CcSEcCtD
Nefazodone—Hypersensitivity—Fluorouracil—colon cancer	0.000231	0.00132	CcSEcCtD
Nefazodone—Haemoglobin—Methotrexate—colon cancer	0.000231	0.00132	CcSEcCtD
Nefazodone—Diarrhoea—Vincristine—colon cancer	0.00023	0.00131	CcSEcCtD
Nefazodone—Haemorrhage—Methotrexate—colon cancer	0.000229	0.00131	CcSEcCtD
Nefazodone—Hepatitis—Methotrexate—colon cancer	0.000229	0.00131	CcSEcCtD
Nefazodone—Myalgia—Capecitabine—colon cancer	0.000228	0.00131	CcSEcCtD
Nefazodone—Chest pain—Capecitabine—colon cancer	0.000228	0.00131	CcSEcCtD
Nefazodone—Arthralgia—Capecitabine—colon cancer	0.000228	0.00131	CcSEcCtD
Nefazodone—Pharyngitis—Methotrexate—colon cancer	0.000228	0.0013	CcSEcCtD
Nefazodone—Anxiety—Capecitabine—colon cancer	0.000228	0.0013	CcSEcCtD
Nefazodone—ABCB1—renal system—colon cancer	0.000227	0.0107	CbGeAlD
Nefazodone—Discomfort—Capecitabine—colon cancer	0.000226	0.00129	CcSEcCtD
Nefazodone—Diarrhoea—Irinotecan—colon cancer	0.000224	0.00128	CcSEcCtD
Nefazodone—Dry mouth—Capecitabine—colon cancer	0.000223	0.00128	CcSEcCtD
Nefazodone—Dizziness—Vincristine—colon cancer	0.000222	0.00127	CcSEcCtD
Nefazodone—Pruritus—Fluorouracil—colon cancer	0.000222	0.00127	CcSEcCtD
Nefazodone—Visual impairment—Methotrexate—colon cancer	0.000221	0.00126	CcSEcCtD
Nefazodone—Confusional state—Capecitabine—colon cancer	0.000221	0.00126	CcSEcCtD
Nefazodone—Oedema—Capecitabine—colon cancer	0.000219	0.00125	CcSEcCtD
Nefazodone—Infection—Capecitabine—colon cancer	0.000218	0.00124	CcSEcCtD
Nefazodone—Erythema multiforme—Methotrexate—colon cancer	0.000217	0.00124	CcSEcCtD
Nefazodone—Dizziness—Irinotecan—colon cancer	0.000216	0.00124	CcSEcCtD
Nefazodone—Shock—Capecitabine—colon cancer	0.000215	0.00123	CcSEcCtD
Nefazodone—Diarrhoea—Fluorouracil—colon cancer	0.000214	0.00123	CcSEcCtD
Nefazodone—Thrombocytopenia—Capecitabine—colon cancer	0.000214	0.00123	CcSEcCtD
Nefazodone—Tinnitus—Methotrexate—colon cancer	0.000214	0.00122	CcSEcCtD
Nefazodone—Tachycardia—Capecitabine—colon cancer	0.000214	0.00122	CcSEcCtD
Nefazodone—Vomiting—Vincristine—colon cancer	0.000214	0.00122	CcSEcCtD
Nefazodone—Rash—Vincristine—colon cancer	0.000212	0.00121	CcSEcCtD
Nefazodone—Hyperhidrosis—Capecitabine—colon cancer	0.000212	0.00121	CcSEcCtD
Nefazodone—Dermatitis—Vincristine—colon cancer	0.000212	0.00121	CcSEcCtD
Nefazodone—HTR2A—liver—colon cancer	0.000211	0.00995	CbGeAlD
Nefazodone—Headache—Vincristine—colon cancer	0.00021	0.0012	CcSEcCtD
Nefazodone—Anorexia—Capecitabine—colon cancer	0.000209	0.00119	CcSEcCtD
Nefazodone—Vomiting—Irinotecan—colon cancer	0.000208	0.00119	CcSEcCtD
Nefazodone—Dizziness—Fluorouracil—colon cancer	0.000207	0.00118	CcSEcCtD
Nefazodone—Rash—Irinotecan—colon cancer	0.000206	0.00118	CcSEcCtD
Nefazodone—Dermatitis—Irinotecan—colon cancer	0.000206	0.00118	CcSEcCtD
Nefazodone—Chills—Methotrexate—colon cancer	0.000206	0.00118	CcSEcCtD
Nefazodone—Headache—Irinotecan—colon cancer	0.000205	0.00117	CcSEcCtD
Nefazodone—Hypotension—Capecitabine—colon cancer	0.000205	0.00117	CcSEcCtD
Nefazodone—Alopecia—Methotrexate—colon cancer	0.000203	0.00116	CcSEcCtD
Nefazodone—Nausea—Vincristine—colon cancer	0.0002	0.00114	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Capecitabine—colon cancer	0.0002	0.00114	CcSEcCtD
Nefazodone—Vomiting—Fluorouracil—colon cancer	0.000199	0.00114	CcSEcCtD
Nefazodone—Fluphenazine—ABCB1—colon cancer	0.000198	0.15	CrCbGaD
Nefazodone—Insomnia—Capecitabine—colon cancer	0.000198	0.00113	CcSEcCtD
Nefazodone—Rash—Fluorouracil—colon cancer	0.000198	0.00113	CcSEcCtD
Nefazodone—Dermatitis—Fluorouracil—colon cancer	0.000197	0.00113	CcSEcCtD
Nefazodone—Paraesthesia—Capecitabine—colon cancer	0.000197	0.00112	CcSEcCtD
Nefazodone—Headache—Fluorouracil—colon cancer	0.000196	0.00112	CcSEcCtD
Nefazodone—CYP3A4—liver—colon cancer	0.000196	0.00921	CbGeAlD
Nefazodone—Dysgeusia—Methotrexate—colon cancer	0.000196	0.00112	CcSEcCtD
Nefazodone—Dyspnoea—Capecitabine—colon cancer	0.000195	0.00112	CcSEcCtD
Nefazodone—Nausea—Irinotecan—colon cancer	0.000194	0.00111	CcSEcCtD
Nefazodone—Back pain—Methotrexate—colon cancer	0.000193	0.0011	CcSEcCtD
Nefazodone—Dyspepsia—Capecitabine—colon cancer	0.000193	0.0011	CcSEcCtD
Nefazodone—CYP2D6—liver—colon cancer	0.000193	0.00907	CbGeAlD
Nefazodone—ADRA2A—lymph node—colon cancer	0.000191	0.00897	CbGeAlD
Nefazodone—Decreased appetite—Capecitabine—colon cancer	0.00019	0.00109	CcSEcCtD
Nefazodone—ABCB1—lymphoid tissue—colon cancer	0.000188	0.00886	CbGeAlD
Nefazodone—Vision blurred—Methotrexate—colon cancer	0.000188	0.00108	CcSEcCtD
Nefazodone—Constipation—Capecitabine—colon cancer	0.000187	0.00107	CcSEcCtD
Nefazodone—Pain—Capecitabine—colon cancer	0.000187	0.00107	CcSEcCtD
Nefazodone—Nausea—Fluorouracil—colon cancer	0.000186	0.00106	CcSEcCtD
Nefazodone—ABCB1—digestive system—colon cancer	0.000186	0.00875	CbGeAlD
Nefazodone—Ill-defined disorder—Methotrexate—colon cancer	0.000185	0.00106	CcSEcCtD
Nefazodone—Anaemia—Methotrexate—colon cancer	0.000185	0.00106	CcSEcCtD
Nefazodone—Feeling abnormal—Capecitabine—colon cancer	0.00018	0.00103	CcSEcCtD
Nefazodone—Malaise—Methotrexate—colon cancer	0.00018	0.00103	CcSEcCtD
Nefazodone—Vertigo—Methotrexate—colon cancer	0.000179	0.00103	CcSEcCtD
Nefazodone—Gastrointestinal pain—Capecitabine—colon cancer	0.000179	0.00102	CcSEcCtD
Nefazodone—Leukopenia—Methotrexate—colon cancer	0.000179	0.00102	CcSEcCtD
Nefazodone—Cough—Methotrexate—colon cancer	0.000174	0.000996	CcSEcCtD
Nefazodone—Urticaria—Capecitabine—colon cancer	0.000174	0.000994	CcSEcCtD
Nefazodone—Abdominal pain—Capecitabine—colon cancer	0.000173	0.000989	CcSEcCtD
Nefazodone—Body temperature increased—Capecitabine—colon cancer	0.000173	0.000989	CcSEcCtD
Nefazodone—Convulsion—Methotrexate—colon cancer	0.000173	0.000989	CcSEcCtD
Nefazodone—ABCB1—bone marrow—colon cancer	0.000171	0.00807	CbGeAlD
Nefazodone—Myalgia—Methotrexate—colon cancer	0.00017	0.000972	CcSEcCtD
Nefazodone—Chest pain—Methotrexate—colon cancer	0.00017	0.000972	CcSEcCtD
Nefazodone—Arthralgia—Methotrexate—colon cancer	0.00017	0.000972	CcSEcCtD
Nefazodone—Discomfort—Methotrexate—colon cancer	0.000168	0.00096	CcSEcCtD
Nefazodone—Confusional state—Methotrexate—colon cancer	0.000164	0.000939	CcSEcCtD
Nefazodone—ABCB1—vagina—colon cancer	0.000164	0.00773	CbGeAlD
Nefazodone—Anaphylactic shock—Methotrexate—colon cancer	0.000163	0.000932	CcSEcCtD
Nefazodone—Infection—Methotrexate—colon cancer	0.000162	0.000926	CcSEcCtD
Nefazodone—Hypersensitivity—Capecitabine—colon cancer	0.000161	0.000922	CcSEcCtD
Nefazodone—Thrombocytopenia—Methotrexate—colon cancer	0.00016	0.000912	CcSEcCtD
Nefazodone—Trifluoperazine—ABCB1—colon cancer	0.000158	0.12	CrCbGaD
Nefazodone—Hyperhidrosis—Methotrexate—colon cancer	0.000158	0.000901	CcSEcCtD
Nefazodone—Asthenia—Capecitabine—colon cancer	0.000157	0.000898	CcSEcCtD
Nefazodone—Anorexia—Methotrexate—colon cancer	0.000155	0.000888	CcSEcCtD
Nefazodone—Pruritus—Capecitabine—colon cancer	0.000155	0.000885	CcSEcCtD
Nefazodone—Quetiapine—ABCB1—colon cancer	0.000154	0.116	CrCbGaD
Nefazodone—Hypotension—Methotrexate—colon cancer	0.000152	0.000871	CcSEcCtD
Nefazodone—Diarrhoea—Capecitabine—colon cancer	0.00015	0.000856	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000149	0.000849	CcSEcCtD
Nefazodone—Insomnia—Methotrexate—colon cancer	0.000147	0.000843	CcSEcCtD
Nefazodone—Paraesthesia—Methotrexate—colon cancer	0.000146	0.000837	CcSEcCtD
Nefazodone—Dyspnoea—Methotrexate—colon cancer	0.000145	0.000831	CcSEcCtD
Nefazodone—Somnolence—Methotrexate—colon cancer	0.000145	0.000828	CcSEcCtD
Nefazodone—Dizziness—Capecitabine—colon cancer	0.000145	0.000828	CcSEcCtD
Nefazodone—Dyspepsia—Methotrexate—colon cancer	0.000143	0.00082	CcSEcCtD
Nefazodone—Decreased appetite—Methotrexate—colon cancer	0.000142	0.00081	CcSEcCtD
Nefazodone—Pain—Methotrexate—colon cancer	0.000139	0.000797	CcSEcCtD
Nefazodone—Vomiting—Capecitabine—colon cancer	0.000139	0.000796	CcSEcCtD
Nefazodone—ABCB1—liver—colon cancer	0.000139	0.00652	CbGeAlD
Nefazodone—Rash—Capecitabine—colon cancer	0.000138	0.000789	CcSEcCtD
Nefazodone—Dermatitis—Capecitabine—colon cancer	0.000138	0.000788	CcSEcCtD
Nefazodone—Headache—Capecitabine—colon cancer	0.000137	0.000784	CcSEcCtD
Nefazodone—Feeling abnormal—Methotrexate—colon cancer	0.000134	0.000768	CcSEcCtD
Nefazodone—Gastrointestinal pain—Methotrexate—colon cancer	0.000133	0.000762	CcSEcCtD
Nefazodone—Nausea—Capecitabine—colon cancer	0.00013	0.000743	CcSEcCtD
Nefazodone—Urticaria—Methotrexate—colon cancer	0.00013	0.00074	CcSEcCtD
Nefazodone—Body temperature increased—Methotrexate—colon cancer	0.000129	0.000736	CcSEcCtD
Nefazodone—Abdominal pain—Methotrexate—colon cancer	0.000129	0.000736	CcSEcCtD
Nefazodone—Hypersensitivity—Methotrexate—colon cancer	0.00012	0.000686	CcSEcCtD
Nefazodone—Asthenia—Methotrexate—colon cancer	0.000117	0.000668	CcSEcCtD
Nefazodone—Pruritus—Methotrexate—colon cancer	0.000115	0.000659	CcSEcCtD
Nefazodone—Diarrhoea—Methotrexate—colon cancer	0.000112	0.000637	CcSEcCtD
Nefazodone—Dizziness—Methotrexate—colon cancer	0.000108	0.000616	CcSEcCtD
Nefazodone—ABCB1—lymph node—colon cancer	0.000106	0.005	CbGeAlD
Nefazodone—Vomiting—Methotrexate—colon cancer	0.000104	0.000592	CcSEcCtD
Nefazodone—Rash—Methotrexate—colon cancer	0.000103	0.000587	CcSEcCtD
Nefazodone—Dermatitis—Methotrexate—colon cancer	0.000103	0.000587	CcSEcCtD
Nefazodone—Headache—Methotrexate—colon cancer	0.000102	0.000584	CcSEcCtD
Nefazodone—Nausea—Methotrexate—colon cancer	9.68e-05	0.000553	CcSEcCtD
